Abstract
Photodynamic Therapy offers multiple advantages to treat nonmelanoma skin cancer compared to conventional treatment techniques such as surgery, radiotherapy or chemotherapy. Among these advantages are particularly relevant its noninvasive nature, the use of non ionizing radiation and its high selectivity. However the therapeutic efficiency of the current clinical protocol is not complete in all the patients and depends on the type of pathology. Emerging strategies to overcome its current shortcomings include the use of nanostructures that can act as carriers for conventional photosensitizers and improve the treatment selectivity and provide a controlled release of the photoactive agent. In this work, a model for photodynamic therapy combined with gold nanocarriers for a photosensitizer commonly used in dermatology is presented and applied to a basal cell carcinoma in order to predict the cytotoxic agent spatial and temporal evolution.
© 2013 SPIE
PDF ArticleMore Like This
F. Fanjul-Vélez, I. Salas-García, L. A. Fernández-Fernández, M. López-Escobar, L. Buelta-Carrillo, N. Ortega-Quijano, and J. L. Arce-Diego
7373_0S European Conference on Biomedical Optics (ECBO) 2009
Sisi Cui and Yueqing Gu
ATh3L.1 Asia Communications and Photonics Conference (ACP) 2013
Félix Fanjul-Vélez and José Luis Arce-Diego
JW4A.119 Frontiers in Optics (FiO) 2016